杰龙制药 GERN
$0.99 +$0.04 (+4.18%)
休市 · Nov 6, 8:20 pm ET · 最新盘后价 $0.99 -0.15%
开盘$0.95
昨收$0.95
当日区间$0.95 – $1.02
成交量13.65M
市值$637.67M
市盈率（TTM）–
股息率–
财报
财报日平均波动±8.0%近16次财报
收涨次数5 / 1631% 的概率
最佳反应+21.6%
最差反应-32.1%
每次财报后次日股价变动
| 季度 | 财报日期 | 时段 | 隐含波动 | 实际波动 | 较隐含波动 |
|---|---|---|---|---|---|
| 2026/Q2 | 5 Aug 2026 | Pre Market | ±37.2% | +21.64% | 符合区间 |
| 2026/Q1 | 6 May 2026 | Pre Market | ±15.2% | -4.24% | 符合区间 |
| 2025/Q4 | 25 Feb 2026 | Pre Market | ±25.6% | -11.79% | 符合区间 |
| 2025/Q3 | 5 Nov 2025 | Pre Market | – | -5.22% | – |
| 2025/Q2 | 6 Aug 2025 | Pre Market | ±29.2% | +15.83% | 符合区间 |
| 2025/Q1 | 7 May 2025 | Pre Market | ±30.0% | -0.76% | 符合区间 |
| 2024/Q4 | 26 Feb 2025 | Pre Market | ±33.5% | -32.07% | 符合区间 |
| 2024/Q3 | 7 Nov 2024 | Pre Market | ±15.9% | +0.47% | 符合区间 |
| 2024/Q2 | 8 Aug 2024 | Pre Market | ±13.5% | +0.88% | 符合区间 |
| 2024/Q1 | 2 May 2024 | Pre Market | ±14.4% | -3.19% | 符合区间 |
| 2023/Q4 | 28 Feb 2024 | Pre Market | ±47.1% | -5.57% | 符合区间 |
| 2023/Q3 | 2 Nov 2023 | Pre Market | ±18.8% | -7.77% | 符合区间 |
| 2023/Q2 | 3 Aug 2023 | After Market | ±16.6% | -6.33% | 符合区间 |
| 2023/Q1 | 11 May 2023 | Pre Market | ±19.1% | +2.48% | 符合区间 |
| 2022/Q4 | 16 Mar 2023 | After Market | ±21.1% | -4.53% | 符合区间 |
| 2022/Q3 | 3 Nov 2022 | Pre Market | ±18.6% | -5.58% | 符合区间 |
"隐含波动"指财报发布前期权市场定价的预期波幅。"波动"指财报发布后首个交易日的股价变化。
基本面
最新报告季度：Q2, ended Jun 2026
营收$57.48M+17.2% YoY
营业利润-$12.65M-1.6% YoY
净利润-$16.68M-1.9% YoY
摊薄每股收益-$0.02+0.0% YoY
自由现金流-$16.05M+41.7% YoY
经营现金流-$15.83M
营收，近8个季度
净利润，近8个季度
盈利能力与资产负债表
毛利率93.5%
营业利润率-17.2%
净利率-33.1%
净资产收益率-28.3%
资产收益率-12.6%
投入资本回报率-14.4%
流动比率6.92
负债/资产比率57.9%
现金及投资$300.85M
总负债$121.13M
净现金（净负债）$179.72M
暂无评论——快来第一个聊聊 GERN。
登录后参与讨论。